Fluorescence Immunoassay Analyzer: How VivaDiag Delivers Rapid, Reliable POCT Results

What a Fluorescence Immunoassay Analyzer Does in Modern Diagnostics

A fluorescence immunoassay (FIA) analyzer occupies a critical role in today's point-of-care testing landscape. By combining fluorescence immunochromatography with photoelectric detection, these instruments enable quantitative or qualitative measurement of multiple clinical parameters from small sample volumes — delivering results in just a few minutes. For healthcare professionals who require rapid, accurate data to support clinical decision-making, the fluorescence immunoassay analyzer has become an indispensable tool across hospital departments, primary care clinics, and reference laboratories alike.

The fundamental value of this technology lies in its speed and versatility. Where traditional laboratory assays may require batch processing, a fluorescence immunoassay analyzer brings quantitative precision directly to the point of care, enabling timely intervention for conditions ranging from cardiac events to thyroid dysfunction, infectious diseases, and inflammatory conditions.

VivaChek's VivaDiag Platform: A Purpose-Built FIA Solution

VivaChek Biotech (Hangzhou) Co., Ltd., founded in August 2013 and headquartered in Hangzhou, Zhejiang, People's Republic of China, has developed a comprehensive fluorescence immunoassay product line centered around the VivaDiag system. Built on a foundation of photoelectric detection and fluorescence immunochromatography, the VivaDiag platform is designed to deliver reliable quantitative and qualitative results from tiny sample sizes within a short timeframe — precisely addressing the need for quick and correct decision-making in professional diagnostic settings.

The VivaDiag Multifunction Meter (Model: VIM220H)

At the core of the VivaChek FIA offering is the VivaDiag Multifunction Meter (Model: VIM220H). This immunofluorescence detection device operates on a photoelectric detection principle and works in conjunction with VivaDiag FIA Test Kits to measure multiple parameters across a wide clinical spectrum. The instrument processes tiny sample volumes and delivers results in just a few minutes, making it practical for both high-throughput professional settings and decentralized point-of-care environments.

The VIM220H is not a standalone product but rather the analytical engine of a broader FIA ecosystem. Its compatibility with a broad menu of VivaDiag test kits gives diagnostic professionals the flexibility to address a wide range of clinical questions using a single platform.

A Broad and Clinically Relevant Test Menu

One of the most significant advantages of the VivaDiag FIA system is the breadth of its test menu. VivaChek has developed FIA test kits spanning numerous clinical categories, enabling the VivaDiag platform to serve diverse diagnostic needs within a single instrument environment.

Cardiac Markers

The cTnI/CK-MB/MYO VivaDiag Cardiac Combo Test Kit provides quantitative determination of cardiac troponin I, creatine kinase-MB, and myoglobin simultaneously from whole blood, serum, or plasma. These cardiac biomarker measurements may serve as indicators for the diagnosis of myocardial injury and can help assess prognosis, making this kit particularly relevant in emergency and acute care settings where rapid triage decisions are essential.

Thyroid Function

• The T3 VivaDiag Triiodothyronine Test Kit (FIA) enables quantitative determination of T3 in human serum or plasma, providing data that can be used as one indicator to evaluate thyroid function.
• The fT3 VivaDiag Free Triiodothyronine Test Kit (FIA) extends this capability to free triiodothyronine measurement from whole blood (fingerstick or venous), serum, or plasma, offering flexible sample input options for clinical operators.

Inflammation and Infection Assessment

• The SAA VivaDiag Serum Amyloid A Protein Test Kit (FIA) supports quantitative determination of serum amyloid A protein from whole blood, serum, or plasma. Measurement of SAA can evaluate viral and bacterial infections, providing clinicians with a rapid inflammatory marker for differential diagnosis.
• The CAL VivaDiag Calprotectin Test Kit (FIA) targets quantitative determination of calprotectin in human feces, aiding management and monitoring of gastrointestinal inflammation caused by inflammatory bowel disease, colorectal cancer, and some enteropathies.

Drug of Abuse Screening

The MOP VivaDiag Morphine Test Kit (FIA) offers quantitative determination of morphine in human hair, providing information for drug of abuse assessment. This unique sample matrix — human hair — distinguishes it from standard urine-based screening and expands the utility of the FIA platform into occupational health and forensic support contexts.

Infectious Disease and SARS-CoV-2

VivaChek's FIA portfolio also includes products targeting Anti-SARS-CoV-2 S and a combined SARS-CoV-2/Flu A/Flu B test, addressing the ongoing need for rapid respiratory pathogen differentiation. These products are listed within the immunofluorescence infectious disease category, reflecting the platform's adaptability to emerging clinical priorities.

Additional Clinical Categories

Beyond the products described above, the VivaDiag FIA lineup extends across additional clinical domains:

• Immunofluorescence — Diabetes
• Immunofluorescence — Renal function
• Immunofluorescence — Hormone
• Immunofluorescence — Tumor markers
• Immunofluorescence — Autoimmune
• Immunofluorescence — Others

This comprehensive coverage means that a single VivaDiag Multifunction Meter installation can support multi-departmental diagnostic workflows without requiring additional analyzer platforms.

Quality Standards Supporting Clinical Confidence

VivaChek's diagnostic products are backed by a quality management system aligned with multiple internationally recognized regulatory frameworks, including FDA 510(k) clearance, European Union CE marking, China NMPA approval, EN ISO 13485 certification, China GMP compliance, FDA QSR (Quality System Regulations), and the international ISO system. For professionals evaluating a fluorescence immunoassay analyzer for clinical or regulatory-sensitive environments, this multi-jurisdiction certification profile provides a meaningful assurance baseline.

Global Reach and Proven Deployment

VivaChek's products are currently available in over 120 countries across the globe. The company operates from its Hangzhou headquarters, with manufacturing facilities in Shaoxing, Zhejiang Province, and additional entities including VivaChek Laboratoires, Inc. in Wilmington, Delaware, USA; Vivachek Diagnostics Inc. in Sacramento, California, USA; VivaChek Life Care in Chennai, India; a Singapore branch; and an India branch. This global infrastructure reflects a company positioned to support diagnostic professionals across diverse healthcare systems and regulatory environments.

VivaChek has also maintained active presence at major international medical exhibitions including MEDICA, Arab Health, CMEF, EASD, FIME, and others from 2014 to 2019, demonstrating sustained engagement with the global diagnostic community.

Practical Considerations for Procurement and Implementation

For facilities evaluating a fluorescence immunoassay analyzer, the VivaDiag platform offers several practical considerations:

• Sample flexibility: Multiple kits support whole blood, serum, plasma, feces, or hair depending on the specific test, reducing pre-analytical processing requirements for many parameters.
• Result speed: The system is designed to return results in just a few minutes, supporting the rapid decision-making timelines that define effective point-of-care testing.
• Menu scalability: The broad library of VivaDiag FIA Test Kits means that a single instrument investment can support evolving departmental testing needs over time.
• Regulatory alignment: The multi-jurisdiction certification framework of VivaChek's quality management system supports procurement across diverse regulatory environments.

For healthcare systems, diagnostic laboratories, and clinical professionals seeking a reliable, multi-parameter fluorescence immunoassay analyzer supported by a broad test menu and globally validated quality standards, the VivaDiag platform from VivaChek Biotech (Hangzhou) Co., Ltd. represents a well-structured option meriting evaluation. Further information is available through the company's official channels at info@vivachek.com.

https://www.vivachek.com/
VivaChek Biotech (Hangzhou) Co., Ltd.